Ulken V, Püschel G P, Jungermann K
Institut für Biochemie, Fachbereich Medizin, Georg-August-Universität, Göttingen.
Biol Chem Hoppe Seyler. 1991 Jun;372(6):401-9. doi: 10.1515/bchm3.1991.372.1.401.
Rat liver was perfused in situ via the portal vein without recirculation: 1) Electrical stimulation of the nerve bundles around hepatic artery and portal vein increased glucose and lactate output, reduced flow and caused an overflow of noradrenaline into the hepatic vein. The alpha-agonist phenylephrine also augmented glucose and lactate output and lowered flow with an ED50 of about 1 microM, while the beta-agonist isoproterenol increased glucose output but reduced lactate output with an ED50 of about 0.2 microM and left flow unaltered. 2) The alpha 1-receptor antagonist prazosin (KI at alpha 1-sites approximately 1 nM, at alpha 2-sites approximately 100 nM) inhibited the nerve stimulation-dependent increase in glucose and lactate output and reduction of flow with an ID50 of about 1 nM, while the alpha 2-receptor antagonist yohimbine (KI at alpha 2-sites approximately 10 nM, at alpha 1-sites approximately 1500 nM) was inhibitory only with an ID50 of about 400 nM. 10 nM prazosin clearly reduced the nerve actions, completely blocked the effects of 1 microM phenylephrine and left the effects of 0.2 microM isoproterenol unaltered. 10 nM yohimbine did not affect the nerve actions nor the effects of phenylephrine or isoproterenol. 3) The beta 1-receptor antagonist metoprolol (KI at beta 1-sites approximately 100 nM, at beta 2-sites approximately 1.2 microM) at 10 microM concentrations did not interfere with the nerve stimulation-dependent increase in glucose and lactate output or the decrease in flow. It did not have any specific alpha-antagonistic influence either on the changes brought about by 1 microM phenylephrine; however, it blocked the beta 2-mediated increase in glucose output by isoproterenol.(ABSTRACT TRUNCATED AT 250 WORDS)
1)电刺激肝动脉和门静脉周围的神经束会增加葡萄糖和乳酸的输出,减少血流量,并导致去甲肾上腺素溢入肝静脉。α-激动剂去氧肾上腺素也会增加葡萄糖和乳酸的输出,并降低血流量,其半数有效剂量(ED50)约为1微摩尔,而β-激动剂异丙肾上腺素会增加葡萄糖输出,但降低乳酸输出,ED50约为0.2微摩尔,且血流量不变。2)α1-受体拮抗剂哌唑嗪(在α1位点的解离常数KI约为1纳摩尔,在α2位点约为100纳摩尔)抑制神经刺激依赖性的葡萄糖和乳酸输出增加以及血流量减少,半数抑制剂量(ID50)约为1纳摩尔,而α2-受体拮抗剂育亨宾(在α2位点的KI约为10纳摩尔,在α1位点约为1500纳摩尔)仅在ID50约为400纳摩尔时具有抑制作用。10纳摩尔的哌唑嗪明显减弱神经作用,完全阻断1微摩尔去氧肾上腺素的作用,而异丙肾上腺素0.2微摩尔的作用不受影响。10纳摩尔的育亨宾既不影响神经作用,也不影响去氧肾上腺素或异丙肾上腺素的作用。3)β1-受体拮抗剂美托洛尔(在β1位点的KI约为100纳摩尔,在β2位点约为1.2微摩尔)在10微摩尔浓度时,不干扰神经刺激依赖性的葡萄糖和乳酸输出增加或血流量减少。它对1微摩尔去氧肾上腺素引起的变化也没有任何特异性的α-拮抗作用;然而,它阻断了异丙肾上腺素介导的β2-受体引起的葡萄糖输出增加。(摘要截短于250字)